Romiplostim for the treatment of thrombocytopenia after allogeneic stem cell transplantation

被引：0
|
作者：
Liga, Maria [1 ]
Spyridis, Nikos [1 ]
Aggelinas, Dimitris [1 ]
Korovila, Chara [1 ]
Triantafyllou, Evangellia [1 ]
Bountouris, Panagiotis [1 ]
Marangos, Markos [1 ]
Spyridonidis, Alexandros [1 ]
机构：
[1] Univ Hosp Patras, Patras, Greece
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P143
引用
收藏
页码：236 / 237
页数：2
相关论文
共 50 条
  • [1] Romiplostim in treatment of thrombocytopenia after allogeneic haematopoietic stem cell transplantation
    Uspenskaya, O.
    Lisukov, I.
    Kulagin, A.
    Bondarenko, S.
    Rudakova, T.
    Slesarchuk, O.
    Afanasyev, B.
    Gorbacheva, R. M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S212 - S212
  • [2] Treatment options for persisting thrombocytopenia after allogeneic stem cell transplantation using romiplostim
    Moskovits, J.
    Ponstingl, E.
    Jarisch, A.
    Soerensen, J.
    Bakhtiar, S.
    Klingebiel, T.
    Bader, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S408 - S408
  • [3] Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation
    Battipaglia, G.
    Ruggeri, A.
    Brissot, E.
    Mamez, A-C
    Malard, F.
    Belhocine, R.
    Vekhoff, A.
    Giannotti, F.
    Ledraa, T.
    Labopin, M.
    Rubio, M-T
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 (12) : 1574 - 1577
  • [4] Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation
    Battipaglia, G.
    Ruggeri, A.
    Mamez, A-C.
    Drevon, L.
    Malard, F.
    Gomez, A.
    Brissot, E.
    Belhocine, R.
    Vekhoff, A.
    Lapusan, S.
    Isnard, F.
    Legrand, O.
    Ledraa, T.
    Labopin, M.
    Rubio, M. -T.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S216 - S216
  • [5] Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation
    G Battipaglia
    A Ruggeri
    E Brissot
    A-C Mamez
    F Malard
    R Belhocine
    A Vekhoff
    F Giannotti
    T Ledraa
    M Labopin
    M-T Rubio
    M Mohty
    Bone Marrow Transplantation, 2015, 50 : 1574 - 1577
  • [6] Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children
    Maximova, Natalia
    Zanon, D.
    Rovere, F.
    Maestro, A.
    Schillani, G.
    Paparazzo, R.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (05) : 626 - 632
  • [7] Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children
    Natalia Maximova
    D. Zanon
    F. Rovere
    A. Maestro
    G. Schillani
    R. Paparazzo
    International Journal of Hematology, 2015, 102 : 626 - 632
  • [8] Romiplostim for Thrombocytopenia Following Allogeneic Stem Cell Transplantation: A Case Series
    Coltoff, Alexander
    Lancman, Guido
    Steinberg, Amir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S306 - S306
  • [9] Treatment of Thrombocytopenia after Allogeneic Stem Cell Transplantation with Eltrombopag
    Kircali, Ekin
    Seval, Guldane Cengiz
    Koyun, Derya
    Ozturk, Cemaleddin
    Uslu, Atilla
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Akan, Hamdi
    Ilhan, Osman
    Gurman, Gunhan
    Beksac, Meral
    Yuksel, Meltem Kurt
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 410 - 411
  • [10] Feasibility and Efficacy of Romiplostim for the Treatment of Persistent Thrombocytopenia after Allogeneic Stem Cell Transplantation. a Single Centre Experience
    Sommer, Charlotte
    Gantner, Andrea
    Wais, Verena
    Neagoie, Adela
    Schnell, Jacqueline
    Doehner, Hartmut
    Bunjes, Donald
    Sala, Elisa
    BLOOD, 2022, 140 : 7603 - 7604
12345